CN109481558A - Chinese medicine composition is preparing the application in fatigue proof drug - Google Patents
Chinese medicine composition is preparing the application in fatigue proof drug Download PDFInfo
- Publication number
- CN109481558A CN109481558A CN201811559822.8A CN201811559822A CN109481558A CN 109481558 A CN109481558 A CN 109481558A CN 201811559822 A CN201811559822 A CN 201811559822A CN 109481558 A CN109481558 A CN 109481558A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- processed
- chinese medicine
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 87
- 229940079593 drug Drugs 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 150000003839 salts Chemical class 0.000 claims description 33
- 235000014101 wine Nutrition 0.000 claims description 33
- 210000003734 kidney Anatomy 0.000 claims description 23
- 210000000988 bone and bone Anatomy 0.000 claims description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 16
- 241000208340 Araliaceae Species 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 12
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000282994 Cervidae Species 0.000 claims description 11
- 241000005787 Cistanche Species 0.000 claims description 11
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 11
- 241000283074 Equus asinus Species 0.000 claims description 11
- 240000006927 Foeniculum vulgare Species 0.000 claims description 11
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 11
- 241000270288 Gekko Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 235000009496 Juglans regia Nutrition 0.000 claims description 11
- 241000282373 Panthera pardus Species 0.000 claims description 11
- 241000287127 Passeridae Species 0.000 claims description 11
- 244000197580 Poria cocos Species 0.000 claims description 11
- 235000008599 Poria cocos Nutrition 0.000 claims description 11
- 244000226566 Psoralea corylifolia Species 0.000 claims description 11
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 11
- 244000235659 Rubus idaeus Species 0.000 claims description 11
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 11
- 210000003056 antler Anatomy 0.000 claims description 11
- 210000001320 hippocampus Anatomy 0.000 claims description 11
- 235000013372 meat Nutrition 0.000 claims description 11
- 235000020234 walnut Nutrition 0.000 claims description 11
- 241000756943 Codonopsis Species 0.000 claims description 10
- 229920002527 Glycogen Polymers 0.000 claims description 10
- 241000405911 Rehmannia glutinosa Species 0.000 claims description 10
- 229940096919 glycogen Drugs 0.000 claims description 10
- 239000004310 lactic acid Substances 0.000 claims description 10
- 235000014655 lactic acid Nutrition 0.000 claims description 10
- 241000143060 Americamysis bahia Species 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 230000034659 glycolysis Effects 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims 3
- 240000007594 Oryza sativa Species 0.000 claims 2
- 235000007164 Oryza sativa Nutrition 0.000 claims 2
- 235000009566 rice Nutrition 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 15
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 206010016256 fatigue Diseases 0.000 description 27
- 241000700159 Rattus Species 0.000 description 13
- 230000002440 hepatic effect Effects 0.000 description 9
- 230000009182 swimming Effects 0.000 description 9
- 241000758789 Juglans Species 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- -1 glidant Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229960003827 isosorbide mononitrate Drugs 0.000 description 2
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019991 rice wine Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 241001582888 Lobus Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OPCRGEVPIBLWAY-QNRZBPGKSA-N ethyl (2E,4Z)-deca-2,4-dienoate Chemical compound CCCCC\C=C/C=C/C(=O)OCC OPCRGEVPIBLWAY-QNRZBPGKSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention provides a kind of Chinese medicine compositions to prepare the application in fatigue proof drug, is related to technical field of traditional Chinese medicines, and the present invention provides Chinese medicine compositions to prepare the application in fatigue proof drug.The Chinese medicine composition has significant curative effect as endurance drug.The drug is improving locomitivity, and slowing down has good effect in terms of sports fatigue, can be used as fatigue proof drug for clinical practice, to the drug make full use of and exploitation plays significance.Meanwhile the Chinese medicine derives from crude drug, is free from side effects, safely and effectively.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, more particularly, to a kind of Chinese medicine composition in preparing fatigue proof drug
Using.
Background technique
Fatigue is a kind of sense of discomfort of subjectivity, is mainly shown as feeling of fatigue, taediumvitae, in progress long-time labour, acutely
It can be perceived under movement or long-time stress, this is a kind of only normal physiological protection reaction, prompts body that should pass through
Rest makes functional recovery, to avoid the further injury to body.However as the aggravation that society strives unexpectedly, rhythm of life adds
Fastly, people are made usually to ignore fatigue, still selection works long hours.It is chronically at fatigue state, it can insulting physical strength, body
Can, body is unbalance, makes one to be difficult to be engaged in or complete certain work larger or that movement is fine and smooth, exquisite that consume one's strength, to make work
Make efficiency decline;On the other hand, chronic fatigue can also make one cutis laxa, and lusterless complexion shows prematurely senile sign;It is long
Phase fatigue cannot be restored, and make human body immune system dysfunction, or even cause immunocompromised, the barrier quilt that body resists the disease
Break, increases the probability of patient.In addition, long-term psychological pressure, hormone disturbance, dysimmunity etc., be cause it is chronic
The main inducing of fatigue syndrome.The work of excess load, excessive pressure and irregular daily life system feel people usually
It is difficult to restore for a long time to feeling of fatigue, taediumvitae, so that people is chronically at sub-health state, there are about 70% people to be in crowd
This state, wherein again high-incidence with the middle-aged and the old.
Based on this, need to find antifatigue substance to delay to work for a long time, make under strenuous exercise or excessive stress
At fatigue occur, or fatigue state is made to be restored to normal condition as early as possible, to make people's sub-health state restore normal or right
Fatigue syndrome generates curative effect.
In view of this, the present invention is specifically proposed.
Summary of the invention
Of the invention is designed to provide Chinese medicine composition and is preparing the application in fatigue proof drug, at least to alleviate
One of the technical problems existing in the prior art.
In order to realize above-mentioned purpose of the invention, the following technical scheme is adopted:
The present invention provides Chinese medicine compositions as described below to prepare the application in fatigue proof drug:
Dog kidney, deer's sinew take the lead mouth and remove pawl sparrow meat, donkey kidney, dried shrimps, pilose antler, hippocampus, extra large maggot, leopard bone processed, gekko,
Ginseng, Radix Astragali, Radix Angelicae Sinensis, Rehmannia glutinosa, radix aconiti lateralis preparata, cortex cinnamomi, Fructus Caryophylli, salt fennel, radix achyranthis bidentatae, salt psoralea corylifolia, Radix Codonopsis, Poria cocos,
Chinese yam, charred CORTEX EUCOMMIAE, rhizoma cibotii, wine Herba Cistanches, walnut kernel, Herba Epimedii processed, salt fry semen astragali complanati, raspberry, fructus lycii, the wine five tastes
Son, Semen Cuscutae, wine Fructus Corni (processed), calcined Dragon's bone and Radix Glycyrrhizae.
Further, effective dosage of the fatigue proof drug is 0.56~1.12mg/kg/ days.
Further, the urea nitrogen that the Chinese medicine composition is generated by reduction protein and/or hepatic glycogen aerobic metabolism
Play the role of endurance.
Further, the Chinese medicine composition plays endurance work by reducing the lactic acid that glucose anerobic glycolysis generates
With.
Further, the Chinese medicine composition includes: 1500-2500 parts of dog kidney, and 20-80 parts of deer's sinew, pilose antler 500-1200
Part, it takes the lead mouth and goes 5500-9500 parts of pawl sparrow meat, 750-1100 parts of donkey kidney, 300-900 parts of dried shrimps, hippocampus 100-1500
Part, extra large maggot 200-1000 parts, leopard bone 10-100 parts processed, 100-850 parts of gekko, 100-1200 parts of Radix Astragali, 300-1200 parts of ginseng,
300-1500 parts of Radix Angelicae Sinensis, 200-750 parts of cortex cinnamomi, 300-1200 parts of radix achyranthis bidentatae, 1500-4500 parts of Fructus Caryophylli, Rehmannia glutinosa 3000-6000
Part, 3500-7000 parts of radix aconiti lateralis preparata, 950-1800 parts of salt fennel, 700-1700 parts of salt psoralea corylifolia, 1200-3000 parts of Radix Codonopsis,
100-1500 parts of rhizoma cibotii, 500-1500 parts of Poria cocos, 950-2500 parts of Chinese yam, 900-1700 parts of walnut kernel, charred CORTEX EUCOMMIAE 300-1200
Part, 3000-6500 parts of wine Herba Cistanches, Herba Epimedii 900-3500 parts processed, salt fries semen astragali complanati 900-1700 parts, Radix Glycyrrhizae 100-900
Part, 1000-3000 parts of raspberry, 600-1700 parts of Semen Cuscutae, 500-1500 parts of fructus lycii, 250-1500 parts of calcined Dragon's bone, wine system
300-1200 parts and 500-1800 parts of wine Fructus Corni (processed) of Schisandra chinensis.
Further, the Chinese medicine composition includes: 1600-2200 parts of dog kidney, and 30-70 parts of deer's sinew, pilose antler 600-1000
Part, it takes the lead mouth and goes 6000-8000 parts of pawl sparrow meat, 800-1000 parts of donkey kidney, 400-800 parts of dried shrimps, hippocampus 200-1200
Part, extra large maggot 250-800 parts, leopard bone 20-80 parts processed, 200-600 parts of gekko, 200-1000 parts of Radix Astragali, 400-1000 parts of ginseng, when
Return 500-1200 parts, 250-600 parts of cortex cinnamomi, 400-1000 parts of radix achyranthis bidentatae, 2000-3000 parts of Fructus Caryophylli, Rehmannia glutinosa 4000-5500
Part, 4000-6000 parts of radix aconiti lateralis preparata, 1000-1600 parts of salt fennel, 800-1500 parts of salt psoralea corylifolia, Radix Codonopsis 1300-2800
Part, 200-1200 parts of rhizoma cibotii, 600-1200 parts of Poria cocos, 1000-2000 parts of Chinese yam, 1000-1500 parts of walnut kernel, charred CORTEX EUCOMMIAE 400-
1000 parts, 4000-6000 parts of wine Herba Cistanches, Herba Epimedii 1000-3000 parts processed, salt fries semen astragali complanati 1000-1500 parts, Radix Glycyrrhizae
200-800 parts, 1200-2800 parts of raspberry, 800-1500 parts of Semen Cuscutae, 600-1300 parts of fructus lycii, calcined Dragon's bone 450-1200
Part, 400-1000 parts and 600-1600 parts of wine Fructus Corni (processed) of wine Fructus Schisandrae (processed).
Further, the drug of the fatigue further includes pharmaceutically acceptable auxiliary material.
Further, the dosage form of the drug of the fatigue includes oral preparation or ejection preparation.
Further, the oral preparation includes tablet, capsule, granule, pill, syrup, oral solution, mouth
Take suspension or Orally taken emulsion.
Further, the ejection preparation includes injection or powder-injection.
The present invention provides Chinese medicine compositions to prepare the application in fatigue proof drug.The Chinese medicine composition includes dog
Kidney, deer's sinew take the lead mouth and remove pawl sparrow meat, donkey kidney, dried shrimps, pilose antler, hippocampus, extra large maggot, leopard bone processed, gekko, ginseng, Radix Astragali,
Radix Angelicae Sinensis, Rehmannia glutinosa, radix aconiti lateralis preparata, cortex cinnamomi, Fructus Caryophylli, salt fennel, radix achyranthis bidentatae, salt psoralea corylifolia, Radix Codonopsis, Poria cocos, Chinese yam, Cortex Eucommiae
Charcoal, rhizoma cibotii, wine Herba Cistanches, walnut kernel, Herba Epimedii processed, salt stir-fry semen astragali complanati, raspberry, fructus lycii, wine Fructus Schisandrae (processed), Tu
Son, wine Fructus Corni (processed), calcined Dragon's bone and Radix Glycyrrhizae have significant curative effect as endurance drug.The drug is improving movement energy
Power has good effect in terms of slowing down sports fatigue, can be used as fatigue proof drug for clinical practice, to the drug
It makes full use of and exploitation plays significance.Meanwhile the Chinese medicine derives from crude drug, is free from side effects, has safely
Effect.
Detailed description of the invention
It, below will be to specific in order to illustrate more clearly of the specific embodiment of the invention or technical solution in the prior art
Embodiment or attached drawing needed to be used in the description of the prior art be briefly described, it should be apparent that, it is described below
Attached drawing is some embodiments of the present invention, for those of ordinary skill in the art, before not making the creative labor
It puts, is also possible to obtain other drawings based on these drawings.
Fig. 1 is the result figure that the Chinese medicine composition that the embodiment of the present invention 2 provides influences tired rat swimming time;
Fig. 2 is the result figure that the Chinese medicine composition that the embodiment of the present invention 2 provides influences tired rat BUN, LD;
Fig. 3 is the result figure that the Chinese medicine composition that the embodiment of the present invention 2 provides influences tired rat hepatic glycogen.
Specific embodiment
Technical solution of the present invention is clearly and completely described below in conjunction with embodiment, it is clear that described reality
Applying example is a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, the common skill in this field
Art personnel every other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
According to an aspect of the invention, there is provided Chinese medicine composition as described below is in preparing fatigue proof drug
Using:
Dog kidney, deer's sinew take the lead mouth and remove pawl sparrow meat, donkey kidney, dried shrimps, pilose antler, hippocampus, extra large maggot, leopard bone processed, gekko,
Ginseng, Radix Astragali, Radix Angelicae Sinensis, Rehmannia glutinosa, radix aconiti lateralis preparata, cortex cinnamomi, Fructus Caryophylli, salt fennel, radix achyranthis bidentatae, salt psoralea corylifolia, Radix Codonopsis, Poria cocos,
Chinese yam, charred CORTEX EUCOMMIAE, rhizoma cibotii, wine Herba Cistanches, walnut kernel, Herba Epimedii processed, salt fry semen astragali complanati, raspberry, fructus lycii, the wine five tastes
Son, Semen Cuscutae, wine Fructus Corni (processed), calcined Dragon's bone and Radix Glycyrrhizae.
Chinese medicine composition of the present invention is currently used primarily in the effect of enriching yin and nourishing kidney, strong brain tonic, declines for body
Weak, qi-blood deficiency, deficiency of kidney-QI is lean and haggard, heartbeat shortness of breath, soreness of waist and ache in legs, the illnesss such as amnesia void asthma.The present invention in order to make on
Stating Chinese medicine composition can be fully utilized, by the discovery of the experimental study creativeness Chinese medicine composition as endurance
Drug has significant curative effect.The drug is improving locomitivity, has good effect, Ke Yizuo in terms of slowing down sports fatigue
For fatigue proof drug be used for clinical practice, to the drug make full use of and exploitation plays significance.Meanwhile the Chinese medicine
Medicament sources are free from side effects in crude drug, safely and effectively.
In some preferred embodiments, effective dosage of the fatigue proof drug is 0.56~1.12mg/
Kg/ days, such as can be, but be not limited to 0.56mg/kg/ days, 0.6mg/kg/ days, 0.65mg/kg/ days, 0.7mg/kg/ days,
0.75mg/kg/ days, 0.8mg/kg/ days, 0.85mg/kg/ days, 0.9mg/kg/ days, 0.95mg/kg/ days, 1mg/kg/ days,
1.05mg/kg/ days, 1.1mg/kg/ days or 1.12mg/kg/ days.
In some preferred embodiments, administration frequency for example can be, but be not limited to twice daily, once a day,
Once every two days, once-weekly or once-monthly administration.Alternatively, medicine provided by the invention can be given in the form of sustained release preparation
Object, in this case it is necessary to less administration frequency.
Dosage and frequency are different in drug user's intracorporal half-life period according to preparation, in addition it is also possible to according to being pre-
The processing of anti-property or therapeutic treatment and it is different.In prophylactic use, given for a long time with the interval of rather low-frequency rate relatively low
Dosage.In therapeutic application, it is sometimes desirable to relatively high dosage is given with relatively short interval, until the progress quilt of disease
Delay or stop, and is preferably up to the individual partially or completely improvement for showing disease symptoms to give and suffer from after this
Person's prevention scheme.
In some preferred embodiments, the Chinese medicine composition has oxo by reducing protein and/or hepatic glycogen
The urea nitrogen for thanking to generation plays the role of endurance.
In other preferred embodiments, the Chinese medicine composition, which passes through, reduces the cream that glucose anerobic glycolysis generates
Acid plays the role of endurance.
In some preferred embodiments, the Chinese medicine composition includes: 1500-2500 parts of dog kidney, such as can be,
But it is not limited to 1500 parts, 1800 parts, 2000 parts, 2200 parts or 2500 parts;20-80 parts of deer's sinew, such as can be, but be not limited to 20
Part, 30 parts, 40 parts, 50 parts, 60 parts, 70 parts or 80 parts;500-1200 parts of pilose antler, such as can be, but be not limited to 500 parts, 800
Part, 1000 parts or 1200 parts;Take the lead mouth and go 5500-9500 parts of pawl sparrow meat, such as can be, but be not limited to 5500 parts,
6000 parts, 6500 parts, 7000 parts, 7500 parts, 8000 parts, 8500 parts, 9000 parts or 9500 parts;750-1100 parts of donkey kidney, such as
It can be, but be not limited to 750 parts, 800 parts, 900 parts, 1000 parts or 1100 parts;300-900 parts of dried shrimps, such as can be, but
It is not limited to 300 parts, 400 parts, 500 parts, 600 parts, 700 parts, 800 parts or 900 parts;100-1500 parts of hippocampus, such as can be, but
It is not limited to 100 parts, 300 parts, 500 parts, 800 parts, 1000 parts, 1200 parts or 1500 parts;Extra large maggot 200-1000 parts, such as can be with
For, but it is not limited to 200 parts, 400 parts, 600 parts, 800 parts or 1000 parts;Leopard bone 10-100 parts processed, such as can be, but be not limited to
10 parts, 20 parts, 30 parts, 40 parts, 50 parts, 60 parts, 70 parts, 80 parts, 90 parts or 100 parts;100-850 parts of gekko, such as can be,
But it is not limited to 100 parts, 200 parts, 300 parts, 400 parts, 500 parts, 600 parts, 700 parts, 800 parts or 850 parts;Radix Astragali 100-1200
Part, such as can be, but be not limited to 100 parts, 300 parts, 500 parts, 800 parts, 1000 parts or 1200 parts;300-1200 parts of ginseng,
Such as can be, but be not limited to 300 parts, 500 parts, 800 parts, 1000 parts or 1200 parts;300-1500 parts of Radix Angelicae Sinensis, such as can be with
For, but it is not limited to 300 parts, 500 parts, 800 parts, 1000 parts, 1200 parts or 1500 parts;200-750 parts of cortex cinnamomi, such as can be,
But it is not limited to 200 parts, 500 parts, 700 parts or 750 parts;300-1200 parts of radix achyranthis bidentatae, such as can be, but be not limited to 300 parts, 500
Part, 800 parts, 1000 parts or 1200 parts;1500-4500 parts of Fructus Caryophylli, such as can be, but be not limited to 1500 parts, 2000 parts,
2500 parts, 3000 parts, 3500 parts, 4000 parts or 4500 parts;3000-6000 parts of Rehmannia glutinosa, such as can be, but be not limited to 3000
Part, 4000 parts, 5000 parts or 6000 parts;3500-7000 parts of radix aconiti lateralis preparata, such as can be, but be not limited to 3500 parts, 4000 parts,
5000 parts, 6000 parts or 7000 parts;950-1800 parts of salt fennel, such as can be, but be not limited to 950 parts, 1200 parts, 1500
Part, 1600 parts or 1800 parts;700-1700 parts of salt psoralea corylifolia, such as can be, but be not limited to 700 parts, 1000 parts, 1200
Part, 1500 parts or 1700 parts;1200-3000 parts of Radix Codonopsis, such as can be, but be not limited to 1200 parts, 1500 parts, 1800 parts,
2000 parts, 2200 parts, 2500 parts, 2800 parts or 3000 parts;100-1500 parts of rhizoma cibotii, such as can be, but be not limited to 100 parts,
300 parts, 500 parts, 800 parts, 1000 parts, 1200 parts or 1500 parts;500-1500 parts of Poria cocos, such as can be, but be not limited to 500
Part, 800 parts, 1000 parts, 1200 parts or 1500 parts;950-2500 parts of Chinese yam, such as can be, but be not limited to 950 parts, 1200
Part, 1500 parts, 1800 parts, 2000 parts, 2200 parts or 2500 parts;900-1700 parts of walnut kernel, such as can be, but be not limited to
900 parts, 1000 parts, 1200 parts, 1500 parts or 1700 parts;300-1200 parts of charred CORTEX EUCOMMIAE, such as can be, but be not limited to 300 parts,
500 parts, 800 parts, 1000 parts or 1200 parts;3000-6500 parts of wine Herba Cistanches, such as can be, but be not limited to 3000 parts,
4000 parts, 5000 parts, 6000 parts or 6500 parts;Herba Epimedii 900-3500 parts processed, such as can be, but be not limited to 900 parts, 1200
Part, 1500 parts, 1800 parts, 2000 parts, 2200 parts, 2500 parts, 2800 parts, 3000 parts, 3200 parts or 3500 parts;Salt fries semen astragali complanati
900-1700 parts, such as can be, but be not limited to 900 parts, 1000 parts, 1200 parts, 1500 parts or 1700 parts;Radix Glycyrrhizae 100-900
Part, such as can be, but be not limited to 100 parts, 200 parts, 500 parts, 600 parts, 800 parts or 900 parts;1000-3000 parts of raspberry,
Such as can be, but be not limited to 1000 parts, 2000 parts or 3000 parts;600-1700 parts of Semen Cuscutae, such as can be, but be not limited to
600 parts, 800 parts, 1000 parts, 1200 parts, 1500 parts or 1800 parts;500-1500 parts of fructus lycii, such as can be, but be not limited to
500 parts, 800 parts, 1000 parts, 1200 parts or 1500 parts;250-1500 parts of calcined Dragon's bone, such as can be, but be not limited to 250 parts,
400 parts, 500 parts, 800 parts, 1000 parts, 1200 parts or 1500 parts;300-1200 parts of wine Fructus Schisandrae (processed), such as can be, but not
It is limited to 300 parts, 500 parts, 800 parts, 1000 parts or 1200 parts;500-1800 parts of wine Fructus Corni (processed), such as can be, but be not limited to
500 parts, 800 parts, 1000 parts, 1200 parts, 1500 parts or 1800 parts.
In some preferred embodiments, the Chinese medicine composition includes: 1600-2200 parts of dog kidney, deer's sinew 30-70
Part, it 600-1000 parts of pilose antler, takes the lead mouth and goes 6000-8000 parts of pawl sparrow meat, 800-1000 parts of donkey kidney, dried shrimps 400-800
Part, 200-1200 parts of hippocampus, extra large maggot 250-800 parts, leopard bone 20-80 parts processed, 200-600 parts of gekko, 200-1000 parts of Radix Astragali, people
400-1000 parts of ginseng, it is 500-1200 parts of Radix Angelicae Sinensis, 250-600 parts of cortex cinnamomi, 400-1000 parts of radix achyranthis bidentatae, 2000-3000 parts of Fructus Caryophylli, ripe
4000-5500 parts of glutinous rehmannia, 4000-6000 parts of radix aconiti lateralis preparata, 1000-1600 parts of salt fennel, 800-1500 parts of salt psoralea corylifolia, party
1300-2800 parts of ginseng, 200-1200 parts of rhizoma cibotii, 600-1200 parts of Poria cocos, 1000-2000 parts of Chinese yam, walnut kernel 1000-1500
Part, 400-1000 parts of charred CORTEX EUCOMMIAE, 4000-6000 parts of wine Herba Cistanches, Herba Epimedii 1000-3000 parts processed, salt fries semen astragali complanati 1000-
1500 parts, 200-800 parts of Radix Glycyrrhizae, 1200-2800 parts of raspberry, 800-1500 parts of Semen Cuscutae, 600-1300 parts of fructus lycii, forge dragon
450-1200 parts of bone, 400-1000 parts and 600-1600 parts of wine Fructus Corni (processed) of wine Fructus Schisandrae (processed).
In some preferred embodiments, the drug of the fatigue further includes pharmaceutically acceptable auxiliary material.
When pharmaceutically acceptable auxiliary material refers to production drug and prescription being dispensed, the excipient and additives used is
Refer in addition to the active ingredient (s, reasonable assessment is had been carried out in terms of safety, and include the substance in pharmaceutical preparation.It is same
Pharmaceutic adjuvant can be used for the pharmaceutical preparation of different way of administration, and play the role of different and purposes.In drug provided by the invention
The pharmaceutically acceptable auxiliary material of middle addition can play the role of excipient, serve as carrier or improve stability, in addition, also having
There are the critical functions such as solubilising, hydrotropy or slow controlled release.
Typical but non-limiting pharmaceutically acceptable auxiliary material includes: solvent, propellant, solubilizer, cosolvent, emulsification
Agent, colorant, binder, disintegrating agent, filler, lubricant, wetting agent, osmotic pressure regulator, stabilizer, glidant, flavoring
Agent, preservative, suspending agent, coating material, aromatic, anti stickness agent, antioxidant, chelating agent, penetration enhancer, pH adjusting agent,
Buffer, plasticizer, surfactant, foaming agent, defoaming agent, thickener, inclusion agents, moisturizer, absorbent, diluent, wadding
One of solidifying agent and deflocculant, filter aid or release retarding agent are a variety of.
In one preferred embodiment, the dosage form of drug includes oral preparation or ejection preparation.
When oral medication, said medicine can be made into and arbitrarily take orally acceptable dosage form, such as can be, but unlimited
In tablet, capsule, granule, pill, syrup, oral solution, oral suspensions or Orally taken emulsion.
Wherein, the carrier that tablet uses generally comprises lactose and cornstarch, and lubricant such as stearic acid in addition can also be added
Magnesium.The diluent that capsule uses generally comprises lactose and dried corn starch.Oral suspensions are then usually by active constituent
It is used in mixed way with suitable emulsifier and suspending agent.
Optionally, some sweeteners, aromatic or colorant can also be added in the above oral dosage form.
When being administered in the form of injection, said medicine can be made into the acceptable dosage form of any injection, such as can be with
For, but it is not limited to injection or powder-injection.
Wherein, workable carrier and solvent include water, Ringer's solution and isotonic sodium chlorrde solution.In addition, sterilizing
Fixed oil also is used as solvent or suspension media, such as monoglyceride or two glyceride.
In order to facilitate it is clearer understand the contents of the present invention, be described in detail as follows now in conjunction with specific embodiment.
Unless otherwise instructed, cell, drug used in the embodiment of the present invention and the equal source of reagent are regular and easily purchase canal
Road:
Guilingji capsules capsule: 0.3g/, lot number 103170408, Shanxi Guang Yuyuan traditional Chinese medicines Co., Ltd;The different sorb of single nitric acid
Ester piece: lot number 07160204, Lunan Beite Pharmaceutical Co., Ltd.;Lactic acid testing cassete: lot number 20180315, Nanjing is built up;Liver/flesh
Glycogen kit: lot number 20180314, Nanjing is built up;Urea nitrogen: lot number 20180313, Nanjing is built up;SD rat, ICR mouse:
SPF grades, Beijing Vital River Experimental Animals Technology Co., Ltd., credit number: SCXK (capital) 2016-0006.
The preparation of 1 Chinese medicine composition of embodiment
In the present embodiment, the Chinese medicine composition is made by the steps:
(a) 750 parts of charred CORTEX EUCOMMIAEs are crushed into powder, it is spare crosses 120 meshes;
(b) 5000 parts of Rehmannia glutinosas and 7500 parts are taken the lead to boil before the water that mouth goes pawl sparrow meat to add 8 times of weight 8 times, every time
It boils 3 hours, merges decocting liquid, filtration, the condensed cream that it is 1.5 in 50 DEG C of relative densities that filtrate, which is condensed into,;
(c) 4000 times of weight yellow rice wine are added to set container 930 parts of donkey kidneys, 1875 parts of dog kidneys, 40 parts of deer's sinews and 500 parts of dried shrimps
Interior, sealing is steamed until yellow rice wine is exhausted by medicinal material, is taken out, be dry, pulverize sieving;
(d) by remaining 29 taste raw material (750 parts of pilose antler, 75 parts of hippocampus 3,375 parts of extra large maggot, 40 parts of leopard bone processed, 240 parts of gekko,
750 parts of ginseng, 625 parts of Radix Astragali, 1000 parts of Radix Angelicae Sinensis, 5000 parts of radix aconiti lateralis preparata, 375 parts of cortex cinnamomi, 2500 parts of Fructus Caryophylli, salt fennel
1250 parts, 750 parts of radix achyranthis bidentatae, 1250 parts of salt psoralea corylifolia, 1875 parts of Radix Codonopsis, 750 parts of Poria cocos, 1500 parts of Chinese yam, 375 parts of rhizoma cibotii,
5000 parts of wine Herba Cistanches, 1250 parts of walnut kernel, 2000 parts of Herba Epimedii processed, 1250 parts of semen astragali complanati of salt stir-fry, 2000 parts of raspberry, Chinese holly
750 parts of matrimony vine, 750 parts of wine Fructus Schisandrae (processed), 1250 parts of Semen Cuscutae, 750 parts of wine Fructus Corni (processed), 625 parts of calcined Dragon's bone and Radix Glycyrrhizae 375
Part) pulverize and sieve;Powder made from step (c) is added, condensed cream made from step (b) is added, proper honey and water, system is added
Ball rushes circle, dry, is coated with step (a) Cortex Eucommiae powdered carbon, polishing, dry to get the Chinese medicine composition, spare.
2 Chinese medicine composition of embodiment is on fatigue proof influence
Select healthy male SD rat, SPF grades, weight (180-200) g, after rat adaptive feeding 3d, by weight with
Machine grouping, every group 10, experiment sets Normal group, model control group, Isosorbide Mononitrate piece 20mg/kg, guilingji capsules
0.12g/kg, Chinese medicine composition (0.28,0.56,1.12) tri- dosage groups of g/kg, totally 7 groups.Each daily gastric infusion 1 of administration group
Secondary, Normal group gives the distilled water of equivalent, and model control group is given corresponding volume 0.5%CMC-Na, continuous 14 days, is administered
Volume is 10ml/kg.bw.
Experiment first day, in addition to Normal group, remaining each group rat is put into adaptability in plastic barrel and swims, the depth of water
20cm, water temperature (24 ± 2) DEG C, one time a day, each 20min, for three days on end.Then begin to formal swimming instruction in 9 days, daily into
2 swimming instructions of row, time are 20min/ times.When there is harmony during individual rats'swimmings and being decreased obviously, sink repeatedly
It takes out.Once not moved it was found that animal is kept afloat, is driven with wooden stick and it is forced to maintain motion state.The 13rd day is tested, each group
Swim after gastric infusion 1h 15min respectively, and orbital vein takes blood, and serum is for measuring urea nitrogen (BUN) and lactic acid (LD);Experiment
14th day, 1h progress power exhausted swimming test after each group is administered respectively, recorded rat from the time for starting to swim to sinking repeatedly.
It after the anesthesia of 40mg/kg yellow Jackets, takes lobus dexter part hepatic tissue to enter -80 DEG C of refrigerators and saves backup, for measuring hepatic glycogen, tie
Fruit sees Tables 1 and 2, Fig. 1-3.
1 Chinese medicine composition of table tired rat swimming time is influenced (N=10)
Compared with Normal group, P < 0.05 △;P < 0.01 , ﹡ P < 0.05, * * compared with model group;N: number of animals.
From table 1 it follows that model control group swimming time significantly shortens compared with Normal group, display has been made
At Tiredness model.Compared with model control group, Chinese medicine composition 1.12g/kg and 0.56g/kg dosage group can prolong to some extent
Long rat swimming time, guilingji capsules 0.12g/kg can equally extend rat swimming time, the different mountain of positive drug single nitric acid
Pear ester has no remarkable effect.
2 Chinese medicine composition of table to tired rat BUN, LD, hepatic glycogen influence (N=10)
Compared with Normal group, P < 0.05 △;P < 0.01 , ﹡ P < 0.05, * * compared with model group;N: number of animals.
From Table 2, it can be seen that model control group hepatic glycogen content significantly reduces compared with Normal group, in serum
BUN, LD are dramatically increased.Compared with model control group, Chinese medicine composition 1.12g/kg, 0.56g/kg can reduce blood to some extent
BUN, LD content in clear reduce hepatic glycogen consumption.Guilingji capsules 0.12g/kg effect is similar, and positive drug Isosorbide Mononitrate has no
Remarkable effect.
By the analysis and summary to the present embodiment result, Chinese medicine composition provided by the invention by reduce protein,
The lactic acid that the urea nitrogen and glucose anerobic glycolysis that hepatic glycogen aerobic metabolism generates generate, improves locomitivity, it is tired to slow down movement
Labor.
Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention., rather than its limitations;To the greatest extent
Pipe present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: its according to
So be possible to modify the technical solutions described in the foregoing embodiments, or to some or all of the technical features into
Row equivalent replacement;And these are modified or replaceed, various embodiments of the present invention technology that it does not separate the essence of the corresponding technical solution
The range of scheme.
Claims (10)
1. Chinese medicine composition as described below is preparing the application in fatigue proof drug:
Dog kidney, deer's sinew take the lead mouth and remove pawl sparrow meat, donkey kidney, dried shrimps, pilose antler, hippocampus, extra large maggot, leopard bone processed, gekko, ginseng,
Radix Astragali, Radix Angelicae Sinensis, Rehmannia glutinosa, radix aconiti lateralis preparata, cortex cinnamomi, Fructus Caryophylli, salt fennel, radix achyranthis bidentatae, salt psoralea corylifolia, Radix Codonopsis, Poria cocos, Chinese yam,
Charred CORTEX EUCOMMIAE, rhizoma cibotii, wine Herba Cistanches, walnut kernel, Herba Epimedii processed, salt fry semen astragali complanati, raspberry, fructus lycii, wine Fructus Schisandrae (processed), Tu
Silk, wine Fructus Corni (processed), calcined Dragon's bone and Radix Glycyrrhizae.
2. application according to claim 1, which is characterized in that effective dosage of the fatigue proof drug is 0.56
~1.12mg/kg/ days.
3. application according to claim 1, which is characterized in that the Chinese medicine composition is by reducing protein and/or liver
The urea nitrogen that glycogen aerobic metabolism generates plays the role of endurance.
4. application according to claim 1, which is characterized in that the Chinese medicine composition is by reducing glucose anerobic glycolysis
The lactic acid of generation plays the role of endurance.
5. application according to claim 1, which is characterized in that the Chinese medicine composition includes: 1500-2500 parts of dog kidney,
It 20-80 parts of deer's sinew, 500-1200 parts of pilose antler, takes the lead mouth and goes 5500-9500 parts of pawl sparrow meat, 750-1100 parts of donkey kidney, do sea
300-900 parts of rice, 100-1500 parts of hippocampus, extra large maggot 200-1000 parts, leopard bone 10-100 parts processed, 100-850 parts of gekko, Radix Astragali
100-1200 parts, 300-1200 parts of ginseng, 300-1500 parts of Radix Angelicae Sinensis, 200-750 parts of cortex cinnamomi, 300-1200 parts of radix achyranthis bidentatae, Fructus Caryophylli
1500-4500 parts, 3000-6000 parts of Rehmannia glutinosa, 3500-7000 parts of radix aconiti lateralis preparata, 950-1800 parts of salt fennel, salt psoralea corylifolia
700-1700 parts, 1200-3000 parts of Radix Codonopsis, 100-1500 parts of rhizoma cibotii, 500-1500 parts of Poria cocos, 950-2500 parts of Chinese yam, walnut
900-1700 parts of benevolence, 300-1200 parts of charred CORTEX EUCOMMIAE, 3000-6500 parts of wine Herba Cistanches, Herba Epimedii 900-3500 parts processed, salt is fried husky
Garden is 900-1700 parts sub-, and 100-900 parts of Radix Glycyrrhizae, 1000-3000 parts of raspberry, 600-1700 parts of Semen Cuscutae, fructus lycii 500-
1500 parts, 250-1500 parts of calcined Dragon's bone, 300-1200 parts and 500-1800 parts of wine Fructus Corni (processed) of wine Fructus Schisandrae (processed).
6. application according to claim 5, which is characterized in that the Chinese medicine composition includes: 1600-2200 parts of dog kidney,
It 30-70 parts of deer's sinew, 600-1000 parts of pilose antler, takes the lead mouth and goes 6000-8000 parts of pawl sparrow meat, 800-1000 parts of donkey kidney, do sea
400-800 parts of rice, 200-1200 parts of hippocampus, extra large maggot 250-800 parts, leopard bone 20-80 parts processed, 200-600 parts of gekko, Radix Astragali 200-
1000 parts, 400-1000 parts of ginseng, 500-1200 parts of Radix Angelicae Sinensis, 250-600 parts of cortex cinnamomi, 400-1000 parts of radix achyranthis bidentatae, Fructus Caryophylli 2000-
3000 parts, 4000-5500 parts of Rehmannia glutinosa, 4000-6000 parts of radix aconiti lateralis preparata, 1000-1600 parts of salt fennel, salt psoralea corylifolia 800-
1500 parts, 1300-2800 parts of Radix Codonopsis, 200-1200 parts of rhizoma cibotii, 600-1200 parts of Poria cocos, 1000-2000 parts of Chinese yam, walnut kernel
1000-1500 parts, 400-1000 parts of charred CORTEX EUCOMMIAE, 4000-6000 parts of wine Herba Cistanches, Herba Epimedii 1000-3000 parts processed, salt is fried husky
Garden is 1000-1500 parts sub-, and 200-800 parts of Radix Glycyrrhizae, 1200-2800 parts of raspberry, 800-1500 parts of Semen Cuscutae, fructus lycii 600-
1300 parts, 450-1200 parts of calcined Dragon's bone, 400-1000 parts and 600-1600 parts of wine Fructus Corni (processed) of wine Fructus Schisandrae (processed).
7. application according to claim 1, which is characterized in that the drug of the fatigue further includes pharmaceutically acceptable auxiliary
Material.
8. application according to claim 1, which is characterized in that the dosage form of the drug of the fatigue includes oral preparation or note
Penetrate preparation.
9. application according to claim 8, which is characterized in that the oral preparation include tablet, capsule, granule,
Pill, syrup, oral solution, oral suspensions or Orally taken emulsion.
10. application according to claim 8, which is characterized in that the ejection preparation includes injection or powder-injection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811559822.8A CN109481558A (en) | 2018-12-18 | 2018-12-18 | Chinese medicine composition is preparing the application in fatigue proof drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811559822.8A CN109481558A (en) | 2018-12-18 | 2018-12-18 | Chinese medicine composition is preparing the application in fatigue proof drug |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109481558A true CN109481558A (en) | 2019-03-19 |
Family
ID=65711011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811559822.8A Pending CN109481558A (en) | 2018-12-18 | 2018-12-18 | Chinese medicine composition is preparing the application in fatigue proof drug |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109481558A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562116A (en) * | 2004-03-26 | 2005-01-12 | 吉林敖东延边药业股份有限公司 | Chinese medicine preparation with invigorating kidney function |
CN1973872A (en) * | 2006-12-04 | 2007-06-06 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn |
-
2018
- 2018-12-18 CN CN201811559822.8A patent/CN109481558A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562116A (en) * | 2004-03-26 | 2005-01-12 | 吉林敖东延边药业股份有限公司 | Chinese medicine preparation with invigorating kidney function |
CN1973872A (en) * | 2006-12-04 | 2007-06-06 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103735838B (en) | One breeding kidney health care medicinal liquor for tonifying kidney and preparation method thereof | |
CN104740412B (en) | A kind of Medicament for Alcoholism composition and preparation method thereof | |
CN102716315A (en) | Kidney yang tonifying health care medicinal liquor and preparation method thereof | |
CN107468747A (en) | A kind of ginseng composition for being advantageous to anticancer, anti-cancer and preparation method thereof | |
CN107006856A (en) | One kind enhancing endurance, raising anti anoxia tolerance nutritional agents and preparation method thereof | |
CN106266112A (en) | A kind of compound Chinese medicinal preparation of invigorating the spleen to arrest diarrhea and preparation method thereof | |
CN103223080B (en) | Traditional Chinese medicinal composition for tranquilizing mind by nourishing the heart and preparation method thereof | |
CN109481558A (en) | Chinese medicine composition is preparing the application in fatigue proof drug | |
CN102423481B (en) | Medicine for treating diabetes and preparation method thereof | |
CN102784230B (en) | Pharmaceutical composition preparation for treating nutritional anemia | |
CN105250989A (en) | Donkey-hide glue small peptide composition for resisting fatigue | |
CN102335387B (en) | Traditional Chinese medicine composition for treating liver stagnation, improving appetite and promoting digestion and preparation method thereof | |
CN111135235A (en) | A composition for preventing and relieving acute alcoholism or alcoholic intoxication | |
CN105168846A (en) | Oral composition with physiological function | |
CN101745042B (en) | Composition with effects of relieving alcoholism and protecting liver and preparation method thereof | |
CN106729518A (en) | A kind of tea beverage of hypotensive and preparation method and application | |
CN101991829B (en) | Medicament for treating stomach illness | |
CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
CN102335388B (en) | Chinese medicine composition for soothing liver, removing stagnation, stimulating appetite, and promoting digestion and preparation method thereof | |
CN100464773C (en) | Yixinshu Injecta for retaliation of Qi and pulse and promotion of blood circulation and removing of blood stasis, and preparing method therefor | |
CN104689151A (en) | Traditional Chinese medicine composition for treating diabetes and use of composition | |
JP2007153816A (en) | Fatigue improver composition | |
CN104056040A (en) | Traditional Chinese medicine preparation for treating insomnia | |
CN102488212A (en) | Health food used for improving sleep, and preparation method thereof | |
CN102949681A (en) | Composition for preventing or treating colds, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190319 |